Skip to main content
Fig. 6 | BMC Infectious Diseases

Fig. 6

From: Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course

Fig. 6

Levels of EBV-specific antibodies after a SARS-CoV-2 infection. (A) VCA IgM, (B) VCA IgG and (C) EBNA IgG antibody levels at the time of the SARS-CoV-2 seropositive blood donation (0 M) and 3 months thereafter (3 M) depicted as relative change to a pre-pandemic blood donation in the year 2019 of each participant. To obtain better descriptiveness of the figure shown, data with > 2.0 relative change of 21 individuals are not depicted in this plot

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us